Autism Impact Fund

Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. It specializes in connecting mental health therapists with children and adults through an online platform that facilitates video calling. Healios provides a clinician-led online family intervention service, which includes interactive psychoeducation for family members and caregivers of individuals affected by mental illness. By integrating advanced technology with clinical expertise and a personal touch, Healios aims to empower patients and their families, helping them understand mental health challenges and adopt healthier habits. The company's mission is to enhance the delivery of care, enabling patients, families, and caregivers to achieve their goals and improve their quality of life.

Floreo Inc. is a developer of a virtual reality learning platform focused on teaching social and communication skills to individuals with autism spectrum disorder, ADHD, and anxiety. Founded in 2016 and based in Washington, D.C., Floreo's application allows supervising adults to monitor and guide users' learning experiences. The platform is utilized by over 100 therapy clinics and school districts, marking Floreo as a pioneer in digital therapeutic reimbursement with an approved CPT 3 reimbursement code. Additionally, the company has partnered with Meta to enhance the accessibility of its virtual reality solutions in public schools, aiming to improve real-world skills for those with developmental challenges.

SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize.

Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

auticon GmbH is a consulting firm based in Berlin, Germany, with additional offices in Munich and Düsseldorf. Founded in 2011, the company specializes in information technology services, particularly in software testing and quality assurance. auticon employs autistic individuals exclusively as software testers, leveraging their unique skills to provide high-quality workmanship in various areas, including static code analysis, functional testing, usability testing, and data analysis. The company's services cater to a diverse clientele, including software producers, IT firms, consulting companies, and public institutions. By focusing on the strengths of its workforce, auticon not only delivers exceptional testing services but also promotes inclusivity within the tech industry.

BioROSA Technologies Inc. is a Belmont, Massachusetts-based company focused on developing blood tests for Autism Spectrum Disorders (ASD). Founded in 2018, the company aims to establish a biologically-based standard of care for ASD through innovative diagnostic tools. These tools enable clinicians to identify individuals at risk for ASD by utilizing blood-based biomarkers and advanced machine learning techniques. BioROSA’s platform not only enhances early detection and diagnosis but also supports therapeutic developments by facilitating patient stratification and assessing pharmacodynamics in clinical trials. This comprehensive approach equips healthcare professionals with the necessary resources to improve patient outcomes through timely intervention.

SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize.

Suggestic's platform enables health-related organizations to build and deliver personalized nutrition programs in a fraction of the time and cost through white label solutions or direct API integration. Powered by proprietary artificial intelligence, the Suggestic platform allows for the encoding of dietary programs as rulesets. It then enables data acquisition from users and members in the form of assessments, lab tests, and devices. Based on the rulesets of the program and the user data, the platform delivers personalized food recommendations in the form of meal plans, smart shopping lists, recipe and restaurant recommendations, food logging, and more.

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapies for Autism Spectrum Disorder (ASD). The company is advancing L1-79, a novel oral treatment designed to improve the core symptoms associated with ASD. This therapy targets both central nervous system and metabolic symptoms, aiming to modulate catecholaminergic pathways. By addressing these pathways, Yamo Pharmaceuticals seeks to enhance socialization and communication skills in individuals with Autism, providing a therapeutic option that directly confronts the challenges faced by those affected by the disorder.

Axial Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for central nervous system diseases and disorders. Based in Waltham, Massachusetts, the company utilizes a microbiome discovery platform that targets the gut-brain axis, allowing for the exploration and creation of innovative therapies aimed at improving the quality of life for patients suffering from neurological conditions. Incorporated in 2013, Axial Biotherapeutics seeks to advance its pipeline of novel treatments to address the unmet needs in the field of CNS disorders.

Joshin, LLC is a company based in Shoreview, Minnesota, that specializes in developing software applications focused on disability care. Its primary product is the Joshin application, which connects families with caregivers who are experienced, qualified, and screened to support individuals with disabilities and neurodivergence. The platform allows users to create personalized care plans that detail the needs, goals, preferences, and dietary requirements of their loved ones, facilitating a tailored approach to care. In addition to connecting families with caregivers, Joshin provides virtual coaching and education on disability issues, guiding families in navigating the complexities of care for individuals with special needs.